Staff
Eastern Virginia Medical SchoolDr. Mauck received her medical degree in 1981 from the University of Michigan and her M.P.H. in 1988 from Johns Hopkins University. She completed her Preventive Medicine residency in Population Dynamics at Johns Hopkins in 1989. Prior to joining CONRAD in 1992, Dr. Mauck served as a consultant to the Population Council's Center for Biomedical Research from 1989 to 1990, and as Assistant Director of gynecologic and reproductive research at R.W. Johnson Pharmaceutical Research Institute from 1990 to 1992. From 1997 to 1998, she was a medical reviewer for the Division of Reproductive and Urological Drug Products at the U.S. Food and Drug Administration. Since 1994, she has also served the Maryland State Department of Health and Mental Hygiene, giving direct patient care in Title X family planning clinics on a part-time basis. Dr. Mauck has co-authored publications relating to clinical research on contraceptives and microbicides, including "The use of colposcopy in assessing vaginal irritation in research" (2000) and "Recommendations for the clinical development of topical microbicides: an update" (2001), both of which were published in AIDS.
Publications
- Baseline variation and associations between subject characteristics and five cytokine biomarkers of vaginal safety among healthy non-pregnant women in microbicide trials
- Reddy female condom: functional performance of a 90-mm shaft length in two clinical studies
- Results of a safety and feasibility study of the diaphragm used with ACIDFORM Gel or K-Y® Jelly
- Safety evaluation of 1% tenofovir gel in healthy men
- Critical next steps for female condom research: report from a workshop
- Biomarker discovery: validation and decision-making in product development
- Biomarkers for evaluating vaginal microbicides and contraceptives: discovery and early validation
- Biomarkers for the Evaluation of Vaginal Microbicides and Contraceptives: Discovery and Early Validation
- Biomarkers of semen exposure
- Comparative crossover study of the PATH Woman's Condom and the FC Female Condom®
- Six-day randomized safety trial of intravaginal lime juice
- Colposcopically observed vascular changes in the cervix in relation to the hormonal levels and menstrual cycle
- SILCS diaphragm: postcoital testing of a new single-size contraceptive device
- Using objective markers to assess participant behavior in HIV prevention trials of vaginal microbicides
- Consistent use of a combination product versus a single product in a safety trial of the diaphragm and microbicide in Harare, Zimbabwe
- A randomized six-day safety study of an antiretroviral microbicide candidate UC781, a non-nucleoside reverse transcriptase inhibitor
- As the world grows: contraception in the 21st century
- Noncomparative contraceptive efficacy of cellulose sulfate gel
- Vaginal distribution of Replens® and K-Y® Jelly using three imaging techniques
- A Phase I study of the functional performance, safety and acceptability of the BufferGel® Duet
- Biomarkers of semen in the vagina: applications in clinical trials of contraception and prevention of sexually transmitted pathogens including HIV
- Fourteen-day safety and acceptability study of the universal placebo gel